Leucettine L41, DYRKs and CLKs Inhibitor

Cat. No.
CLIA-0130225
Product Size
1 mg 5 mg Custom Size

Product Overview

Description
Potent inhibitor of DYRKs and CLKs.
Purity
> 98%
Form
Solid
Target
DYRKs and CLKs
Biological Description
Potent inhibitor of DYRKs and CLKs. Interacts also with GSK-3α/β, CK2 and PIM1. Interacts with the complex IKfyve/Vac14/Fig4. Modulates alternative splicing of pre-mRNA in various cellular systems. Neuroprotective against APP-induced cell death. Useful to study and modulate pre-RNA splicing. Potential compound for Alzheimer's disease and diseases involving abnormal pre-mRNA splicing. Potential compound to study Down syndrome (inhibition of DYRK1A). Neuroprotective against glutamate-induced cell death.
CAS Number
1112978-84-3
Solubility Overview
Soluble in DMSO and in EtOH.

Chemical Properties

Chemical Name
2-anilino-4-(1,3-benzodioxol-5-ylmethylidene)-1H-imidazol-5-one
Molecular Weight (Da)
307.30
Molecular Formula
C17H13N3O3
PubChem Identifier
SMILES
C1OC2=C(O1)C=C(C=C2)C=C3C(=O)NC(=N3)NC4=CC=CC=C4

Storage & Handling

Storage Instructions
Shipped at 4 °C. Store at -20 °C. Store in the dark. This product is air and light sensitive and impurities can occur as a result of air oxidation or due to metabolism by microbes.

For Research Use Only. Not For Clinical Use.

Online Inquiry